Navigating the ADHD Treatment Landscape from Childhood to Adulthood
Ann Childress, MD; Stephen Mateka, DO; Michelle Voegels, PMHNP-BC, and Michael Asbach, DMSc, PA-C discuss how to effectively diagnose and manage ADHD in pediatric populations through a multidisciplinary approach that includes case-based insights, pharmacologic and non-pharmacologic treatments, developmental considerations, family dynamics, and strategies for transitioning care across childhood and adolescence
EP. 1: Overview of Attention Deficit/Hyperactivity Disorder
May 1st 2025A panelist discusses how attention deficit/hyperactivity disorder (ADHD) as a common neurodevelopmental disorder characterized by inattention and hyperactive-impulsive behavior, affecting approximately 10.5% of children in the US aged 3 to 17 years with higher prevalence in adolescents and boys, highlighting its various symptoms, potential causes including genetic factors, and mentioning upcoming discussions about treatment options and transitioning care from pediatric to adult settings.
Watch
EP. 2: ADHD in Elementary School Age Child: Patient Case 1
Panelists discuss how ADHD presents in a 10-year-old boy with combined presentation symptoms, emphasizing the importance of seeing difficulties across multiple settings and noting the genetic component when family history is present.
Watch
EP. 3: ADHD Diagnosis Criteria
Panelists discuss how the DSM-5-TR criteria for ADHD require at least 6 of 9 symptoms in either inattentive or hyperactive-impulsive domains, with inattentive presentations often going unrecognized especially in females and highly intelligent students.
Watch
